item management s discussion and analysis of financial condition and results of operations management s discussion and analysis of financial condition and results of operations maxxim develops  manufactures and distributes a diversified group of specialty medical products 
the company has grown significantly during the past five years 
net sales increased from  in to  in  a compound annual growth rate of 
this growth resulted primarily from acquisitions of established businesses or product lines 
maxxim medical  inc  a delaware subsidiary of maxxim  operates the company s three divisions case management  argon medical  and maxxim medical europe 
set forth below is a brief description of the most significant acquisitions made by the company since see note of the notes to consolidated financial statements 
sterile concepts 
in july  the company acquired the outstanding common stock of sterile concepts through completion of a tender offer 
sterile concepts assembles  packages and distributes sterile custom procedure trays for hospitals  outpatient surgery centers and medical clinics 
as a result of the acquisition  the company s case management division became the second largest producer of custom procedure trays in the united states and holds an approximate market share in this product segment 
glove operations 
in june  the company acquired the glove operations from becton dickinson 
the gloves  which are sold under such brand names as tru touch  sensicare  tradition  eudermic  dextren and neolon  include latex and non latex surgical and examination versions 
since being acquired  the north american operations have been included in the case management division and the european operations have been a part of maxxim medical europe 
this acquisition gave the company a leading worldwide market share in non latex medical examination gloves 
medica 
in january  the company purchased medica bv  a netherlands corporation 
medica s operations included manufacturing  fabricating  distributing and selling various types of disposable medical supplies in europe  principally in the netherlands and belgium 
since july  the medica products have been sold in europe through the maxxim medical europe division 
sterile design 
in july  maxxim acquired the custom procedure tray operations of sterile design from a division of johnson johnson 
as a result of this acquisition  the company became the third largest provider of sterile custom procedure trays in the united states 
the following discussion should be read in conjunction with the consolidated financial statements and the related notes thereto and other detailed information appearing elsewhere herein 
results of operations the following table presents selected financial information for the periods indicated as a percentage of net sales and sets forth the percentage dollar increase decrease of such items from period to period 
percentage change fiscal year ended from prior period vs 
vs 
net sales gross profit marketing and selling expenses general and administrative expenses nonrecurring charges n a income from operations interest expense other income expense  net income before income taxes income taxes net income fiscal compared to net sales net sales for fiscal were  a increase over the  reported for fiscal the case management division had sales of  for fiscal versus sales of  for fiscal this increase is due to a full year of sales from the sterile concepts acquisition see note of the notes to consolidated financial statements 
the argon division had sales of  in fiscal  lower than the  recorded in fiscal this decline is attributable to competitive factors primarily affecting the patient monitoring product line 
maxxim medical europe s fiscal sales of  were lower than the fiscal sales of  due to foreign exchange rates 
excluding the impact of foreign currency translation  maxxim medical europe s fiscal sales were higher than fiscal gross profit the company s gross profit was  for fiscal  a increase over the  reported for fiscal the gross profit margin declined to in fiscal from in fiscal primarily due to the acquisition of sterile concepts which had a gross margin of in fiscal 
however  gross margins have improved each quarter since the acquisition from in the fourth quarter of fiscal to in the fourth quarter of fiscal operating expenses marketing and selling expenses increased from  in fiscal to  in fiscal  however  as a percentage of net sales  these expenses dropped from to in the same periods 
general and administrative expenses increased from  in fiscal to  in fiscal  but once again  as a percentage of net sales  these expenses dropped from to for the respective periods 
the company estimates that operating expenses for fiscal included approximately  of one time expenses as a result of the acquisition of sterile concepts 
the reduction of expense rates resulted from the leveraging of the sterile concepts operations with the existing operations of the company 
income from operations income from operations increased to  in fiscal  from  in fiscal excluding the one time expenses in fiscal mentioned above  income from operations increased from  or of net sales in fiscal to  or of net sales in fiscal interest expense the company s interest expense increased to  in fiscal from  in fiscal the increase in interest expense is the direct result of the increase in outstanding debt incurred to finance the acquisition of sterile concepts 
income taxes maxxim s effective income tax rate was in both fiscal and fiscal the company s effective tax rate is higher than the statutory rate as a result of nondeductible amortization expenses resulting from goodwill recorded in past acquisitions 
net income as a result of the foregoing  fiscal net income was  as compared to fiscal net income of  fully diluted earnings per share were and for fiscal years and respectively 
fiscal compared to net sales net sales for fiscal were  a increase over the  reported for fiscal the case management division had sales of  for fiscal versus sales of  for fiscal this increase is primarily due to a full year of sales for the glove operations acquired in june and three months of sales from the sterile concepts acquisition see note of the notes to consolidated financial statements 
the argon division had sales of  in fiscal  higher than the  recorded in fiscal sales increased in almost all product lines with the largest increase coming from pressure monitoring kits  a product line which was expanded in february of maxxim medical europe s fiscal sales of  were higher than the  recorded for fiscal this increase is attributable to the european operations of the glove operation which was acquired in june the henley healthcare division was sold in april and had sales of  for fiscal versus a full year sales figure of  for fiscal gross profit the company s gross profit was  for fiscal  a increase over the  reported for fiscal the gross profit margin declined to in fiscal from in fiscal primarily due to the acquisition of sterile concepts which had a gross margin of in fiscal and continued pricing pressure on procedure trays for most of the year 
operating expenses marketing and selling expenses increased from  in fiscal to  in fiscal  however  as a percentage of net sales these expenses dropped from to in the same periods 
general and administrative expenses increased from  in fiscal to  in fiscal  but once again  as a percentage of net sales  these expenses dropped from to for the respective periods 
the company estimates that operating expenses for fiscal included approximately  of one time expenses as a result of the acquisition of sterile concepts 
income from operations income from operations increased to  in fiscal  from  in fiscal excluding the nonrecurring charge in fiscal and the one time expenses in fiscal mentioned above  income from operations increased from  or of net sales in fiscal to approximately  or of net sales in fiscal interest expense the company s interest expense increased to  in fiscal from  in fiscal the increase in interest expense is the direct result of the new debt facilities created to finance the acquisition of sterile concepts 
interest expense for fiscal also includes nonrecurring financing fees of approximately  related to bridge financing established in connection with the sterile concepts acquisition 
income taxes maxxim s effective income tax rate was in fiscal and in fiscal the company s effective tax rate is higher than the statutory rate as a result of increased nondeductible amortization expenses resulting from goodwill recorded from past acquisitions 
net income as a result of the foregoing  fiscal net income was  as compared to fiscal net income of  fully diluted earnings per share were and 
for fiscal years and respectively 
liquidity and capital resources at november   the company had cash and cash equivalents of  working capital of  long term liabilities of  and shareholders equity of  cash flow from operations was  in fiscal versus  in fiscal cash flow from operations was favorably impacted by a reduction in operations working capital of  primarily resulting from improved management of accounts receivable and inventory 
in the first quarter of fiscal  the company received  from the sale of its marketable equity securities 
a resulting one time gain of  was included in other income in fiscal during fiscal  the company repaid  of bank debt resulting in a term loan balance of  and a revolver balance of  at fiscal year end 
as a result of debt repayments  the company had  of available credit under its revolver facility on november   and received a basis point reduction in its borrowing rate during the fourth quarter due to improved financial ratios 
on october   the company called for redemption  in principal amount of its  debentures effective as of november  as of november   of the debentures had converted into common stock and debt issuance costs of  related to these converted debentures were written off to additional paid in capital in fiscal on november   the company called for the redemption of the remaining outstanding principal amount of the debentures effective as of december  see note of the notes to consolidated financial statements 
on may  the company issued  shares of common stock pursuant to a senior management stock purchase plan at per share  the closing stock price on april  the stock was issued in exchange for an aggregate of million in notes due may  from the participants 
these notes have been recorded as subscriptions receivable and are included in the equity section of the balance sheet see note of the notes to consolidated financial statements 
the company has considered the impact of year issues on its computer systems and applications 
however  management believes that all of its current software is or will be year compliant in sufficient time and without significant impact on the financial results or prospects of the company 
the company believes that its present cash balances together with internally generated cash flows and borrowings under its existing credit facility will be sufficient to meet its future working capital requirements 
inflation the company believes inflation has not had a material effect on its results of operations for the past three years 
historically  the company believes it has been able to minimize the effect of inflation by increasing the selling prices of its products  improving its manufacturing efficiency and increasing its employee productivity 
foreign currency the company s results of operations and the value of its foreign assets are affected by fluctuations in foreign currency exchange rates 
the impact of changes in exchange rates on results of operations has been minimal since a majority of the company s exports are contracted in the company s functional currencies 
the company can not yet determine the impact of the euro on its financial statements or operations 
foreign currency transaction gains and losses are included in the consolidated statements of operations 
forward looking statements statements  either written or oral  that are not historical facts and which express the company s expectation for the future with respect to financial performance or operating strategies are forward looking statements within the meaning of section e of the securities exchange act of these statements are made to provide the public with management s assessment of the company s business 
caution must be taken to consider these statements in light of the following factors the company assumes that products in development will be introduced successfully and on schedule  the company will make acquisitions which contribute to profitability  key distributors will make purchases at the same level as their sales  demand for the company s products will follow recent growth trends  competitors will not introduce new products which will substantially reduce maxxim s market share in its most significant product lines  and the company will continue to manufacture high quality products at competitive costs and maintain or increase product pricing 
in the event any of the above factors do not occur as management anticipates  actual results could differ materially from the expectations expressed in the forward looking statements 
further information relating to factors that could cause actual results to differ from those anticipated is included but not limited to information under the heading business in this form k report 
the company disclaims any intention or obligation to update or revise forward looking statements  whether as a result of new information  future events or otherwise 
new accounting pronouncements information regarding the impact of new accounting pronouncements on the results of operations  financial position or cash flows is set forth in note of the notes to consolidated financial statements under the caption new accounting pronouncements 
item a quantitative and qualitative disclosures about market risk not applicable to the company for this annual report on form k 

